Form 4: HealthEquity CEO Scott Cutler Reports Stock Transactions
SEC Form 4 Filing
Scott Cutler, CEO of HealthEquity, Inc., reports the acquisition and disposal of common stock and restricted stock units.
Summary
- On April 2, 2025, Scott Cutler, the President and CEO of HealthEquity, Inc., reported transactions involving the company's stock.
- Cutler acquired 45,076 shares of common stock at $0 and disposed of 122,316 shares.
- Following these transactions, Cutler beneficially owns 122,316 shares of common stock.
- The report also details restricted stock units that vest over time, starting with 25% on April 1, 2026, and then 6.25% each quarter for the following twelve quarters.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing, reflecting neutral sentiment as it reports factual transactions.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the CEO's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 01/10/2025 | Power of Attorney given by Mr. Cutler was previously filed with the U.S. Securities and Exchange Commission. |
| 04/02/2025 | Date of the reported stock transactions. |
| 04/01/2026 | First vesting date for 25% of the restricted stock units. |
| 04/04/2025 | Date of signature for the report. |
Keywords
HealthEquity, Scott Cutler, Stock Transactions, Form 4, SEC, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.